{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:20:40Z","timestamp":1787163640788,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01DK068158"],"award-info":[{"award-number":["R01DK068158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.coph.2017.10.013","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T08:30:46Z","timestamp":1510302646000},"page":"112-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Pharmacological management of gastroesophageal reflux disease in infants: current opinions"],"prefix":"10.1016","volume":"37","author":[{"given":"Mohamed A","family":"El-Mahdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma A","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan R","family":"Jadcherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2017.10.013_bib0180","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPG.0b013e31819de871","volume":"49","author":"Vandenplas","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0185","doi-asserted-by":"crossref","first-page":"e1684","DOI":"10.1542\/peds.2013-0421","article-title":"Gastroesophageal reflux: management guidance for the pediatrician","volume":"131","author":"Lightdale","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.coph.2017.10.013_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40272-012-0004-2","article-title":"Gastroesophageal reflux disease in neonates and infants: when and how to treat","volume":"15","author":"Czinn","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.coph.2017.10.013_sbref0195","series-title":"Physiology of the Gastrointestinal Tract","article-title":"Physiology of aerodigestive refelxes in neonates and adults","author":"Jadcherla","year":"2012"},{"key":"10.1016\/j.coph.2017.10.013_bib0200","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2174\/1566524014666141021145419","article-title":"Evidence for up-regulation of purinergic receptor genes associating with TRPV1 receptors and neurotrophic factors in the inflamed human esophagus","volume":"14","author":"Shieh","year":"2014","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.coph.2017.10.013_bib0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2982.2007.00947.x","article-title":"Effect of reflux-induced inflammation on transient receptor potential vanilloid one (TRPV1) expression in primary sensory neurons innervating the oesophagus of rats","volume":"19","author":"Banerjee","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2017.10.013_bib0210","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MPG.0000000000000968","article-title":"Temporal association between reflux-like behaviors and gastroesophageal reflux in preterm and term infants","volume":"62","author":"Funderburk","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1542\/hpeds.2013-0036","article-title":"Practice variance, prevalence, and economic burden of premature infants diagnosed with GERD","volume":"3","author":"Jadcherla","year":"2013","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.coph.2017.10.013_sbref0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.03.059","article-title":"Neonatal histamine-2 receptor antagonist and proton pump inhibitor treatment at United States children's hospitals","volume":"174","author":"Slaughter","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.coph.2017.10.013_bib0225","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/pr.2015.149","article-title":"Gestational and postnatal modulation of esophageal sphincter reflexes in human premature neonates","volume":"78","author":"Jadcherla","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.coph.2017.10.013_sbref0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00455-017-9792-4","article-title":"Effects of esophageal acidification on troublesome symptoms: an approach to characterize true acid GERD in dysphagic neonates","volume":"32","author":"Sivalingam","year":"2017","journal-title":"Dysphagia"},{"key":"10.1016\/j.coph.2017.10.013_sbref0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MPG.0000000000000395","article-title":"Body positioning and medical therapy for infantile gastroesophageal reflux symptoms","volume":"59","author":"Loots","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl. 2","key":"10.1016\/j.coph.2017.10.013_bib0240","first-page":"S6","article-title":"Non-pharmacological therapies for GERD in infants and children","volume":"53","author":"van der Pol","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0245","first-page":"CD003502","article-title":"Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years","author":"Craig","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2017.10.013_bib0250","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2010-2719","article-title":"Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review","volume":"127","author":"van der Pol","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.coph.2017.10.013_bib0255","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamapediatrics.2014.1273","article-title":"Efficacy and safety of histamine-2 receptor antagonists","volume":"168","author":"van der Pol","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.coph.2017.10.013_bib0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","article-title":"Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics","volume":"15","author":"Ward","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.coph.2017.10.013_bib0265","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00228-008-0538-y","article-title":"Proton pump inhibitors: an update of their clinical use and pharmacokinetics","volume":"64","author":"Shi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.coph.2017.10.013_bib0270","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPG.0b013e318176b2cb","article-title":"Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease","volume":"46","author":"Gilger","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0275","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.2011.2035","article-title":"Lansoprazole for children with poorly controlled asthma: a randomized controlled trial","volume":"307","author":"Writing Committee for the American Lung Association Asthma Clinical Research C","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2017.10.013_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2008.09.054","article-title":"Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease","volume":"154","author":"Orenstein","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.coph.2017.10.013_bib0285","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MPG.0b013e3181c2bf41","article-title":"Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1\u201311 months old with symptomatic GERD","volume":"50","author":"Winter","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0290","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1542\/peds.2005-1655","article-title":"Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children","volume":"117","author":"Canani","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.coph.2017.10.013_bib0295","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2036.2009.04229.x","article-title":"Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection","volume":"31","author":"Turco","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.013_bib0300","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1345\/aph.1M519","article-title":"Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease","volume":"44","author":"Higginbotham","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.coph.2017.10.013_bib0305","first-page":"CD008550","article-title":"Pharmacological treatment of children with gastro-oesophageal reflux","author":"Tighe","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2017.10.013_bib0310","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2036.2010.04545.x","article-title":"The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants","volume":"33","author":"Corvaglia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.013_sbref0315","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MPG.0000000000000521","article-title":"Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants","volume":"60","author":"Ummarino","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0320","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MPG.0000000000000657","article-title":"Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide","volume":"60","author":"Mt-Isa","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0325","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/gutjnl-2011-300926","article-title":"Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period","volume":"61","author":"Rohof","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.coph.2017.10.013_bib0330","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-2036.2011.04629.x","article-title":"Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain","volume":"33","author":"Krarup","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.013_bib0335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jpeds.2006.05.029","article-title":"Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial","volume":"149","author":"Omari","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.coph.2017.10.013_bib0340","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2011.01868.x","article-title":"Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study","volume":"24","author":"Rohof","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2017.10.013_bib0345","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00005176-200403000-00017","article-title":"Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease","volume":"38","author":"Kawai","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.013_bib0350","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/MPG.0b013e3182a2747b","article-title":"Baclofen for the treatment of pediatric GERD","volume":"57","author":"Vadlamudi","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217300668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217300668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T11:42:31Z","timestamp":1603280551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489217300668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"alternative-id":["S1471489217300668"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2017.10.013","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological management of gastroesophageal reflux disease in infants: current opinions","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2017.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}